Reported Standalone quarterly numbers for Shukra Pharmaceuticals are:Net Sales at Rs 2.30 crore in December 2022 down 20.3% from Rs. 2.89 crore in December 2021.
Quarterly Net Profit at Rs. 0.03 crore in December 2022 down 45.93% from Rs. 0.05 crore in December 2021.
EBITDA stands at Rs. 0.56 crore in December 2022 up 12% from Rs. 0.50 crore in December 2021.
Shukra Pharma EPS has decreased to Rs. 0.16 in December 2022 from Rs. 0.31 in December 2021.
| Shukra Pharma shares closed at 72.50 on February 17, 2023 (BSE) and has given -62.41% returns over the last 6 months and -4.98% over the last 12 months. |
| Shukra Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'22 | Sep'22 | Dec'21 | | Net Sales/Income from operations | 2.30 | 3.72 | 2.89 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 2.30 | 3.72 | 2.89 | | EXPENDITURE | | Consumption of Raw Materials | 2.16 | 2.38 | 0.12 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -1.88 | -0.88 | 0.13 | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.17 | 1.17 | 1.15 | | Depreciation | 0.46 | 0.45 | 0.37 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.56 | 0.58 | 1.12 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.17 | 0.02 | 0.00 | | Other Income | 0.27 | 0.03 | 0.13 | | P/L Before Int., Excpt. Items & Tax | 0.10 | 0.05 | 0.13 | | Interest | 0.05 | 0.04 | 0.04 | | P/L Before Exceptional Items & Tax | 0.05 | 0.01 | 0.09 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.05 | 0.01 | 0.09 | | Tax | 0.02 | -0.07 | 0.04 | | P/L After Tax from Ordinary Activities | 0.03 | 0.08 | 0.05 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 0.03 | 0.08 | 0.05 | | Equity Share Capital | 1.57 | 1.57 | 1.57 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.16 | 0.49 | 0.31 | | Diluted EPS | 0.16 | 0.49 | 0.31 | | EPS After Extra Ordinary | | Basic EPS | 0.16 | 0.49 | 0.31 | | Diluted EPS | 0.16 | 0.49 | 0.31 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
